Novozymes A/S (OTCMKTS:NVZMY) Sees Strong Trading Volume – Should You Buy?

Shares of Novozymes A/S (OTCMKTS:NVZMY) saw an uptick in trading volume on Friday . 136,923 shares traded hands during trading, an increase of 40% from the previous session’s volume of 97,533 shares.The stock last traded at $58.61 and had previously closed at $57.65.

Novozymes A/S Stock Performance

The company has a market cap of $24.44 billion, a P/E ratio of 42.11, a price-to-earnings-growth ratio of 1.03 and a beta of 1.11. The company has a quick ratio of 1.00, a current ratio of 0.72 and a debt-to-equity ratio of 0.12. The stock’s 50-day moving average price is $59.44 and its 200 day moving average price is $61.48.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.79 by ($0.44). The firm had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a return on equity of 6.37% and a net margin of 13.96%. As a group, research analysts expect that Novozymes A/S will post 1.82 EPS for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).